MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HR-13-0000895
Nexwin Pharma Private Limited
Nexwin Pharma Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.89 Cr
▼ 4% YoY
Net profit · FY 2024
₹4.58 Lakh
Net margin 0.9%
EBITDA · FY 2024
₹28.85 Lakh
EBITDA margin 5.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Nexwin Pharma Private Limited
Data last updated:
Nexwin Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR2020PTC088818.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kali Charan Jaiswal and Jyoti Jaiswal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.No – 315 1/A P – II Panchkula, Haryana, India – 134113.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.89 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹4.58 Lakh (net margin 0.9%) and EBITDA of ₹28.85 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 81% over three years.
Court records list 4 cases involving the company, including 4 filed by the company; 2 cases are pending.
Nexwin Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0000895).
Company details
CIN U24239HR2020PTC088818
Registration Number 088818
Incorporation Date 31 August 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-HR-13-0000895
Recognitions & Rankings of Nexwin Pharma
Contact details
Nexwin Pharma Private Limited's registered office is in Panchkula, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP.No – 315 1/A P – II Panchkula, Haryana, India – 134113
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nexwin Pharma Private Limited, buy the company report.
Comprehensive company report
Nexwin Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nexwin Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nexwin Pharma Private Limited, buy the company report.
Financials of Nexwin Pharma Private Limited
FY 2025 filings availableNexwin Pharma Private Limited reported revenue of ₹4.89 Cr (down 4% YoY) for FY 2024.
Revenue · FY 2024
₹4.89 Cr ▼ 4%
Net profit · FY 2024
₹4.58 Lakh margin 0.9%
EBITDA · FY 2024
₹28.85 Lakh margin 5.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 81%
EBITDA CAGR growth
1 year
▲ 113%
3 years · compounded
▲ 219%
Revenue fell 4% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 81%. EBITDA rose 113% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹28.85 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹4.58 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.9% | |||
| Net Profit Margin | 0.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nexwin Pharma Private Limited, buy the company report.
Board of directors of Nexwin Pharma Private Limited
Nexwin Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kali Charan Jaiswal | Director | 31 Aug 2020 | 6 Years 1 Months | Current |
| Jyoti Jaiswal | Director | 31 Aug 2020 | 6 Years 1 Months | Current |
Peer comparison
Nexwin Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Virtuarc Private Limited | ₹4.91 Cr (FY 2023) | 41.0% | Hyderabad, Telangana, India | |||
| Bhandari Medicals Pvt. Ltd | ₹4.9 Cr (FY 2025) | -1.0% | N.G.H.Road, Jodhpur, Rajasthan, India | |||
| Sanfegan Biotech Private Limited | ₹4.9 Cr (FY 2024) | 62.0% | Ernakulam, Kerala, India | |||
| Nexwin Pharma Private Limitedthis company | ₹4.89 Cr (FY 2024) | ₹4.58 Lakh | 0.9% | -4.0% | Panchkula, Haryana, India | |
| Caventis Pharma Private Limited | ₹4.88 Cr (FY 2024) | -11.0% | Delhi, India |
To see the full peer comparison of Nexwin Pharma Private Limited, buy the company report.
Auditor
Nexwin Pharma Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2023 | 018361N |
Shareholding
The shareholding of Nexwin Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nexwin Pharma Private Limited, buy the company report.
Legal cases
Nexwin Pharma Private Limited has 4 court cases on record: 4 filed by Nexwin Pharma. 2 cases are pending and 2 are disposed.
Total cases
4
Filed by the company
4
Pending
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Court case (CS37) | Filed by the company against M/S Jahnavi Medical Store and 1 other | Pending |
| District court, Panchkula, Haryana | Court case (CS37) | Filed by the company against M/S Chamunda Medical Agency and 1 other | Pending |
| District court, Panchkula, Haryana | Court case (CS37) | Filed by the company against M/S Goel Pharma and 1 other | Disposed |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Anshika Drug Distributors and 1 other | Disposed |
To see the full case history of Nexwin Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexwin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nexwin Pharma Private Limited has 1 active EPFO establishment as of Mar 22, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Nexwin Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nexwin Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Jyoti Jaiswal was appointed as Director on 31 Aug 2020.
AGM
Nexwin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nexwin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Jyoti Jaiswal was appointed as Director.
Appointed
Kali Charan Jaiswal was appointed as Director.
Incorporation
31 Aug 2020
Nexwin Pharma Private Limited was registered on 31 Aug 2020 with Roc Haryana & aged 6 years 1 month as per MCA records.
Frequently asked questions
Nexwin Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 August 2020 (6+ years old) and is registered under CIN U24239HR2020PTC088818.
Nexwin Pharma has 2 current directors:
- Kali Charan Jaiswal - Director
- Jyoti Jaiswal - Director
The latest financial statements of Nexwin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Nexwin Pharma is U24239HR2020PTC088818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexwin Pharma has 4 court cases on record: 4 filed by the company. 2 are pending.
Nexwin Pharma was incorporated on 31 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Nexwin Pharma by revenue are Virtuarc Private Limited, Bhandari Medicals Pvt. Ltd, Sanfegan Biotech Private Limited, Caventis Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Jyoti Jaiswal was appointed as Director on 31 Aug 2020. Kali Charan Jaiswal was appointed as Director on 31 Aug 2020.
Yes, Nexwin Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0000895).
The registered office of Nexwin Pharma is at P.No – 315 1A P – II Panchkula, Haryana, India – 134113.
Nexwin Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.